Document ID: chunk:federal_register_of_legislation:F2019L00251:reg:9:p2
Version: federal_register_of_legislation:F2019L00251
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 5853–8465

the Schedule 1 - Dictionary.
(17)      taking oral isotretinoin or oral acitretin for a continuous period of at least one year before the clinical onset of blepharitis, and where treatment has ceased, the clinical onset of blepharitis has occurred within 30 days of cessation;
(18)      being a prisoner of war at the time of the clinical worsening of blepharitis;
(19)      having an infection of the affected eyelid at the time of the clinical worsening of blepharitis;
Note: infection of the affected eyelid is defined in the Schedule 1 - Dictionary.
(20)      having an infestation of the affected eyelid region, due to a parasite from the specified list of parasites, at the time of the clinical worsening of blepharitis;
Note: specified list of parasites is defined in the Schedule 1 - Dictionary.
(21)      having seborrhoeic dermatitis of the periocular region at the time of the clinical worsening of blepharitis;
(22)      having rosacea of the periocular region at the time of the clinical worsening of blepharitis;
(23)      having psoriasis of the periocular region at the time of the clinical worsening of blepharitis;
(24)      having discoid lupus erythematosus of the periocular region at the time of the clinical worsening of blepharitis;
(25)      having ocular or periocular exposure to an allergen within the 48 hours before the clinical worsening of blepharitis;
Note: allergen is defined in the Schedule 1 - Dictionary.
(26)      having an irritant substance exposure to the region of the affected eye at the time of the clinical worsening of blepharitis;
Note: irritant substance is defined in the Schedule 1 - Dictionary.
(27)      having mustard gas exposure to the region of the affected eye at the time of the clinical worsening of blepharitis;
(28)      undergoing a course of therapeutic radiation for cancer, where the region of the affected eye was in the field of radiation, at the time of the clinical worsening of blepharitis;
(29)      having a benign or malignant neoplasm affecting the affected eyelid at the time of the clinical worsening of blepharitis;
(30)      having dry eye disease at the time of the clinical worsening of blepharitis;
Note: dry eye disease is defined in the Schedule 1 - Dictionary.
(31)      having diabetes mellitus at the time of the clinical worsening of blepharitis;
(32)      being in an immunocompromised state as specified at the time of the clinical worsening of blepharitis;
Note: immunocompromised state as specified is defined in the Schedule 1 - Dictionary.
(33)      inability to obtain appropriate clinical management for blepharitis.